Skip to main content
Erschienen in: World Journal of Surgery 8/2016

26.04.2016 | Original Scientific Report

Amputation Versus Limb-Salvage Surgery in Patients with Osteosarcoma: A Meta-analysis

verfasst von: Gang Han, Wen-Zhi Bi, Meng Xu, Jin-Peng Jia, Yan Wang

Erschienen in: World Journal of Surgery | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

Background

This meta-analysis compared survival and function in patients with limb osteosarcoma treated with limb-salvage surgery (LSS) versus amputation or rotationplasty.

Methods

Medline, Cochrane, EMBASE, and Google Scholar were searched until November 30, 2015 for studies reporting Musculoskeletal Tumor Society (MSTS) scores and survival rates in osteosarcoma patients. Differences between patients undergoing LSS versus ablative surgery were analyzed based on MSTS scores and postoperative survival rates.

Results

Of 1330 patients in the studies analyzed, 934 underwent LSS, and 662 were treated with amputation. A random-effects model was applied due to heterogeneity among studies (Q statistic = 1.829, I 2 = 0 %, p = 0.767). No difference was found in post-operative local recurrence rate between amputees and patients receiving LSS. The 5-year survival rate was significantly lower with amputation compared with LSS (OR 0.628; 95 % CI 0.431–0.913, p = 0.015). The 2-year survival rate was not different between amputation and LSS. In addition, amputees had lower MSTS scores than those undergoing LSS (difference in means = −4.46 %, 95 % CI 6.49–2.45 %, p < 0.001).

Conclusions

LSS results in higher 5-year survival rates and better functional outcomes as indicated by MSTS scores in patients with limb osteosarcomas.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Simon MA, Aschliman MA, Thomas N et al (1986) Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am 68(9):1331–1337PubMed Simon MA, Aschliman MA, Thomas N et al (1986) Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. J Bone Joint Surg Am 68(9):1331–1337PubMed
2.
Zurück zum Zitat Samardziski M, Zafiroski G, Tolevska C et al (2008) Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery). Prilozi 29(2):309–323PubMed Samardziski M, Zafiroski G, Tolevska C et al (2008) Treatment of non-metastatic high-grade osteosarcoma (study of 30 cases treated with Scandinavian osteosarcoma protocol XIV and surgery). Prilozi 29(2):309–323PubMed
3.
Zurück zum Zitat Hogendoorn PC, Group EEW, Athanasou N, et al (2010) Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v204–v213 Hogendoorn PC, Group EEW, Athanasou N, et al (2010) Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v204–v213
4.
Zurück zum Zitat Tan PX, Yong BC, Wang J et al (2012) Analysis of the efficacy and prognosis of limb-salvage surgery for osteosarcoma around the knee. Eur J Surg Oncol 38(12):1171–1177CrossRefPubMed Tan PX, Yong BC, Wang J et al (2012) Analysis of the efficacy and prognosis of limb-salvage surgery for osteosarcoma around the knee. Eur J Surg Oncol 38(12):1171–1177CrossRefPubMed
5.
Zurück zum Zitat Tsuchiya H, Tomita K (1992) Prognosis of osteosarcoma treated by limb-salvage surgery: the ten-year intergroup study in Japan. Jpn J Clin Oncol 22(5):347–353PubMed Tsuchiya H, Tomita K (1992) Prognosis of osteosarcoma treated by limb-salvage surgery: the ten-year intergroup study in Japan. Jpn J Clin Oncol 22(5):347–353PubMed
6.
Zurück zum Zitat Ferrari S, Palmerini E, Staals EL et al (2009) The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the Italian Rizzoli experience. Impact on the future. Cancer Treat Res 152:275–287CrossRefPubMed Ferrari S, Palmerini E, Staals EL et al (2009) The treatment of nonmetastatic high grade osteosarcoma of the extremity: review of the Italian Rizzoli experience. Impact on the future. Cancer Treat Res 152:275–287CrossRefPubMed
7.
Zurück zum Zitat Jeon DG, Song WS (2010) How can survival be improved in localized osteosarcoma? Expert Rev Anticancer Ther 10(8):1313–1325CrossRefPubMed Jeon DG, Song WS (2010) How can survival be improved in localized osteosarcoma? Expert Rev Anticancer Ther 10(8):1313–1325CrossRefPubMed
8.
Zurück zum Zitat Ayerza MA, Farfalli GL, Aponte-Tinao L et al (2010) Does increased rate of limb-sparing surgery affect survival in osteosarcoma? Clin Orthop Relat Res 468(11):2854–2859CrossRefPubMedPubMedCentral Ayerza MA, Farfalli GL, Aponte-Tinao L et al (2010) Does increased rate of limb-sparing surgery affect survival in osteosarcoma? Clin Orthop Relat Res 468(11):2854–2859CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Aksnes LH, Bauer HC, Jebsen NL et al (2008) Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. J Bone Joint Surg Br 90(6):786–794CrossRefPubMed Aksnes LH, Bauer HC, Jebsen NL et al (2008) Limb-sparing surgery preserves more function than amputation: a Scandinavian sarcoma group study of 118 patients. J Bone Joint Surg Br 90(6):786–794CrossRefPubMed
10.
Zurück zum Zitat Yin K, Liao Q, Zhong D et al (2012) Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture. Exp Ther Med 4(5):889–894PubMedPubMedCentral Yin K, Liao Q, Zhong D et al (2012) Meta-analysis of limb salvage versus amputation for treating high-grade and localized osteosarcoma in patients with pathological fracture. Exp Ther Med 4(5):889–894PubMedPubMedCentral
11.
Zurück zum Zitat Ferguson PC, McLaughlin CE, Griffin AM et al (2010) Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma. J Surg Oncol 102(2):120–124CrossRefPubMed Ferguson PC, McLaughlin CE, Griffin AM et al (2010) Clinical and functional outcomes of patients with a pathologic fracture in high-grade osteosarcoma. J Surg Oncol 102(2):120–124CrossRefPubMed
12.
Zurück zum Zitat Scully SP, Ghert MA, Zurakowski D et al (2002) Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am 84-A(1):49–57PubMed Scully SP, Ghert MA, Zurakowski D et al (2002) Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am 84-A(1):49–57PubMed
13.
Zurück zum Zitat Sluga M, Windhager R, Lang S et al (1999) Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma. Clin Orthop Relat Res 358:120–127CrossRefPubMed Sluga M, Windhager R, Lang S et al (1999) Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma. Clin Orthop Relat Res 358:120–127CrossRefPubMed
14.
Zurück zum Zitat Tunn PU, Pomraenke D, Goerling U et al (2008) Functional outcome after endoprosthetic limb-salvage therapy of primary bone tumours—a comparative analysis using the MSTS score, the TESS and the RNL index. Int Orthop 32(5):619–625CrossRefPubMed Tunn PU, Pomraenke D, Goerling U et al (2008) Functional outcome after endoprosthetic limb-salvage therapy of primary bone tumours—a comparative analysis using the MSTS score, the TESS and the RNL index. Int Orthop 32(5):619–625CrossRefPubMed
15.
Zurück zum Zitat Moga C, Guo B, Schopflocher D et al (2012) Development of a quality appraisal tool for case series studies using a modified delphi technique. Institute of Health Economics, Edmonton, AB Moga C, Guo B, Schopflocher D et al (2012) Development of a quality appraisal tool for case series studies using a modified delphi technique. Institute of Health Economics, Edmonton, AB
16.
Zurück zum Zitat Reddy KI, Wafa H, Gaston CL et al (2015) Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins? Bone Joint J 97-B(1):115–120CrossRefPubMed Reddy KI, Wafa H, Gaston CL et al (2015) Does amputation offer any survival benefit over limb salvage in osteosarcoma patients with poor chemonecrosis and close margins? Bone Joint J 97-B(1):115–120CrossRefPubMed
17.
Zurück zum Zitat Deng ZP, Ding Y, Puri A et al (2015) The surgical treatment and outcome of nonmetastatic extremity osteosarcoma with pathological fractures. Chin Med J (Engl) 128(19):2605–2608CrossRef Deng ZP, Ding Y, Puri A et al (2015) The surgical treatment and outcome of nonmetastatic extremity osteosarcoma with pathological fractures. Chin Med J (Engl) 128(19):2605–2608CrossRef
18.
Zurück zum Zitat Mavrogenis AF, Abati CN, Romagnoli C et al (2012) Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res 470(6):1735–1748CrossRefPubMedPubMedCentral Mavrogenis AF, Abati CN, Romagnoli C et al (2012) Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res 470(6):1735–1748CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Wu X, Cai ZD, Chen ZR et al (2012) A preliminary evaluation of limb salvage surgery for osteosarcoma around knee joint. PLoS One 7(3):e33492CrossRefPubMedPubMedCentral Wu X, Cai ZD, Chen ZR et al (2012) A preliminary evaluation of limb salvage surgery for osteosarcoma around knee joint. PLoS One 7(3):e33492CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Samardziski M, Zafiroski G, Tolevska C et al (2009) Limb-sparing in patients with non-metastatic high-grade osteosarcoma. J BUON 14(1):63–69PubMed Samardziski M, Zafiroski G, Tolevska C et al (2009) Limb-sparing in patients with non-metastatic high-grade osteosarcoma. J BUON 14(1):63–69PubMed
21.
Zurück zum Zitat Grimer RJ, Taminiau AM, Cannon SR (2002) Surgical outcomes in osteosarcoma. J Bone Joint Surg Br 84(3):395–400CrossRefPubMed Grimer RJ, Taminiau AM, Cannon SR (2002) Surgical outcomes in osteosarcoma. J Bone Joint Surg Br 84(3):395–400CrossRefPubMed
22.
Zurück zum Zitat Rougraff BT, Simon MA, Kneisl JS et al (1994) Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am 76(5):649–656PubMed Rougraff BT, Simon MA, Kneisl JS et al (1994) Limb salvage compared with amputation for osteosarcoma of the distal end of the femur. A long-term oncological, functional, and quality-of-life study. J Bone Joint Surg Am 76(5):649–656PubMed
23.
Zurück zum Zitat Springfield DS, Schmidt R, Graham-Pole J et al (1988) Surgical treatment for osteosarcoma. J Bone Joint Surg Am 70(8):1124–1130PubMed Springfield DS, Schmidt R, Graham-Pole J et al (1988) Surgical treatment for osteosarcoma. J Bone Joint Surg Am 70(8):1124–1130PubMed
24.
Zurück zum Zitat Kim MS, Lee SY, Lee TR et al (2009) Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol 20(5):955–960CrossRefPubMed Kim MS, Lee SY, Lee TR et al (2009) Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol 20(5):955–960CrossRefPubMed
25.
26.
Zurück zum Zitat Bacci G, Forni C, Longhi A et al (2007) Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol 96(2):118–123CrossRefPubMed Bacci G, Forni C, Longhi A et al (2007) Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol 96(2):118–123CrossRefPubMed
27.
Zurück zum Zitat Bacci G, Longhi A, Versari M et al (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106(5):1154–1161CrossRefPubMed Bacci G, Longhi A, Versari M et al (2006) Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution. Cancer 106(5):1154–1161CrossRefPubMed
28.
Zurück zum Zitat Ferrari S, Bertoni F, Mercuri M et al (2001) Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol 12(8):1145–1150CrossRefPubMed Ferrari S, Bertoni F, Mercuri M et al (2001) Predictive factors of disease-free survival for non-metastatic osteosarcoma of the extremity: an analysis of 300 patients treated at the Rizzoli Institute. Ann Oncol 12(8):1145–1150CrossRefPubMed
29.
Zurück zum Zitat Honegger HP, Cserhati MD, Exner GU et al (1991) Zurich experience with preoperative, high dose methotrexate-containing chemotherapy in patients with extremity osteosarcomas (OSA). Ann Oncol 2(7):489–494PubMed Honegger HP, Cserhati MD, Exner GU et al (1991) Zurich experience with preoperative, high dose methotrexate-containing chemotherapy in patients with extremity osteosarcomas (OSA). Ann Oncol 2(7):489–494PubMed
30.
Zurück zum Zitat Bacci G, Ferrari S, Longhi A et al (2001) Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. J Chemother 13(1):93–99CrossRefPubMed Bacci G, Ferrari S, Longhi A et al (2001) Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. J Chemother 13(1):93–99CrossRefPubMed
31.
Zurück zum Zitat Carsi B, Rock MG (2002) Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res 397:53–61CrossRefPubMed Carsi B, Rock MG (2002) Primary osteosarcoma in adults older than 40 years. Clin Orthop Relat Res 397:53–61CrossRefPubMed
32.
Zurück zum Zitat Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20(3):776–790CrossRefPubMed Bielack SS, Kempf-Bielack B, Delling G et al (2002) Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20(3):776–790CrossRefPubMed
33.
Zurück zum Zitat Davis AM, Bell RS, Goodwin PJ (1994) Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12(2):423–431PubMed Davis AM, Bell RS, Goodwin PJ (1994) Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12(2):423–431PubMed
34.
Zurück zum Zitat Bacci G, Ferrari S, Mercuri M et al (1998) Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand 69(3):230–236CrossRefPubMed Bacci G, Ferrari S, Mercuri M et al (1998) Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy. Acta Orthop Scand 69(3):230–236CrossRefPubMed
35.
Zurück zum Zitat Gaston CL, Nakamura T, Reddy K et al (2014) Is limb salvage surgery safe for bone sarcomas identified after a previous surgical procedure? Bone Joint J 96-B(5):665–672CrossRefPubMed Gaston CL, Nakamura T, Reddy K et al (2014) Is limb salvage surgery safe for bone sarcomas identified after a previous surgical procedure? Bone Joint J 96-B(5):665–672CrossRefPubMed
36.
Zurück zum Zitat Gelderblom H, Jinks RC, Sydes M et al (2011) European Osteosarcoma Intergroup. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur J Cancer 47(6):895–902CrossRefPubMed Gelderblom H, Jinks RC, Sydes M et al (2011) European Osteosarcoma Intergroup. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials. Eur J Cancer 47(6):895–902CrossRefPubMed
37.
Zurück zum Zitat Kong CB, Song WS, Cho WH et al (2012) Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma. Clin Orthop Relat Res 470:1482–1490CrossRefPubMed Kong CB, Song WS, Cho WH et al (2012) Local recurrence has only a small effect on survival in high-risk extremity osteosarcoma. Clin Orthop Relat Res 470:1482–1490CrossRefPubMed
38.
Zurück zum Zitat Mei J, Zhu XZ, Wang ZY et al (2014) Functional outcomes and quality of life in patients with osteosarcoma treated with amputation versus limb-salvage surgery: a systematic review and meta-analysis. Arch Orthop Trauma Surg 134(11):1507–1516CrossRefPubMed Mei J, Zhu XZ, Wang ZY et al (2014) Functional outcomes and quality of life in patients with osteosarcoma treated with amputation versus limb-salvage surgery: a systematic review and meta-analysis. Arch Orthop Trauma Surg 134(11):1507–1516CrossRefPubMed
39.
Zurück zum Zitat Ottaviani G, Robert RS, Huh WW et al (2013) Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents: limb salvage versus amputation. Cancer 119(20):3727–3736CrossRefPubMed Ottaviani G, Robert RS, Huh WW et al (2013) Sociooccupational and physical outcomes more than 20 years after the diagnosis of osteosarcoma in children and adolescents: limb salvage versus amputation. Cancer 119(20):3727–3736CrossRefPubMed
40.
Zurück zum Zitat MacKenzie EJ, Bosse MJ, Castillo RC et al (2004) Functional outcomes following trauma-related lower-extremity amputation. J Bone Joint Surg Am 86-A(8):1636–1645PubMed MacKenzie EJ, Bosse MJ, Castillo RC et al (2004) Functional outcomes following trauma-related lower-extremity amputation. J Bone Joint Surg Am 86-A(8):1636–1645PubMed
Metadaten
Titel
Amputation Versus Limb-Salvage Surgery in Patients with Osteosarcoma: A Meta-analysis
verfasst von
Gang Han
Wen-Zhi Bi
Meng Xu
Jin-Peng Jia
Yan Wang
Publikationsdatum
26.04.2016
Verlag
Springer International Publishing
Erschienen in
World Journal of Surgery / Ausgabe 8/2016
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-016-3500-7

Weitere Artikel der Ausgabe 8/2016

World Journal of Surgery 8/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.